A Prospective, Randomized, Multicentric and Single-blinded Study on Accuracy and Safety of Ultrasound (US) Guided Percutaneous Needle Biopsy of Peripheral Lung Lesion Compared With Computed TomogrAphy (CT) Guided Needle Biopsy
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 236
- 试验地点
- 4
- 主要终点
- Rate of diagnostic samples vs rate of non diagnostic samples assessed by the histological reports, detecting the ones positive for malignant neoplasm or specific benign process out of the totality of procedures for both US-guided and CT-guided biopsy
研究概览
简要总结
A non-sponsored prospective randomized single-blind national multicenter interventional study which aims to compare the diagnostic accuracy between US-guided percutaneous lung needle biopsies and CT-guided in peripheral lung lesions. Secondary endpoints are:
- onset of number and type of complications during and after the procedure, within the first three hour;
- exposition to ionizing radiation, in milligray(mGy);
- patient comfort during the procedure;
- duration of the procedure,
详细描述
Peripherical pulmonary lesions without endobronchial lesions (LPP) are nowadays more and more frequently found in clinical practice, and it's only assumable that this tendency will keep growing in the future, alongside the increasing use of thoracic CT scanning and the proven efficacy in lung cancer screening. Even though most of these lesions are benign, it's still important to be able to identify neoplastic lesions in an early stage.
The gold standard for diagnosis definition is biopsy, which can be performed by four paths: surgery, transbronchial endoscopy (TBB), endobronchial endoscopy (EBB) or percutaneous (TTNA).
Surgical option is the most reliable one in terms of diagnostic yield, at the expense of an increased risk of complications, post-operative recovery in hospital staying and costs, compared with the other three procedures; due to the safety and diagnostic yield of TBB, EBB and TTNA, the surgical approach, just for the purpose of diagnosis, resulted in a secondary choice in the diagnostic flowchart of LPP. In addiction, given the high probability of the benign nature of the LPP, the choice of a less invasive approach in the diagnostic phase is even more reasonable. Even though technology really improved the diagnostic yield of LPP, overall sensibility is around 70-80%, influenced by many factors such as: localization and extension of the lesion, presence of bronchus sign, sampling techniques and procedural errors. The incidence of complications for this type of sampling, mostly presented by pneumothorax, is around 4%.
The TTNA is a largely used procedure for diagnosing LPP and it can be conducted using both a CT guided and an ultrasound guided approach, as long as the lesion is located in direct contact with the thoracic wall. CT scan guide has the perk of giving a more precise view of: densitometric feature of the lesions, their location and the connections with the anatomical structures surrounding them. LPP CT guided TTNA (tTTNA) can reach a diagnostic yield of 98% in case of an experienced operator, where ultrasound guided reaches about 93.4%, only slightly inferior to the prior one. Both tTTNA and ultrasound guided percutaneous transthoracic biopsy (eTTNA) are useful techniques not only for pulmonary parenchymal diseases but also in case of pleural lesions, allowing simultaneous sampling and visualization of the lesions in exam.
Peripheric pleural lesions can also be approached via thoracoscopy (both medical and surgical) with a diagnostic efficiency between 91-95% for malignant lesions and 100% for Tuberculosis-related lesions. However, the high risk of complications after the procedure, the duration of hospitalization post-surgery and the costs, suggest choosing between eTTNA and tTTNA as the very first diagnostic step in pleural lesions as well. Moreover, the diagnostic yield of tTTNA and eTTNA is respectively of 89% and 90%.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- Single (Investigator)
盲法说明
anatomopathologist is blinded about the procedure which has been executed
入排标准
- 年龄范围
- 18 Years 至 90 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Willingness and ability to provide free and informed consent. Age older then 18 years old.
- •Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing
排除标准
- •Inability to provide free and informed consent, in the absence of an available legal guardian.
- •Age younger then 18 years old.
- •Terminal neoplastic diseases/ palliative care patients.
- •Patients with one lung, anatomical of functional.
- •Severe non-treatable blood clothing disfunctions.
- •Severe organ failure (pulmonary, renal, hepatic or cardiac).
- •Women in state of pregnancy.
结局指标
主要结局
Rate of diagnostic samples vs rate of non diagnostic samples assessed by the histological reports, detecting the ones positive for malignant neoplasm or specific benign process out of the totality of procedures for both US-guided and CT-guided biopsy
时间窗: 1 month
For diagnostic sampling is meant the ability to diagnose a malignant neoplasm or a specific benign process (such as benignant neoplasia, granulomatous inflammation). For nondiagnostic sample is meant the finding of a non-specific benign process or that the sample is not adequate/sufficient. For benign non-specific is meant a histological diagnosis suggesting a benign process without any evidence of malignancy but that does not give the specific information to achieve a definitive diagnosis. In any case that does not include a diagnostic confirmation of a non-specific benign lesion by a surgical approach, TTNA will be considered a true negative only after a follow-up documenting a downsizing of at least 20% in the major axial diameter or a stability in sizing for at least one year from the lesion itself.
次要结局
- Rate of complications that can be occur during the procedures assessed by physiological parameter, VAS scale, radiography(3 hours)
- Amount of Ionizing radiation to which the patient is exposed calculated in mGy(1 hour)
- Comfort of the patient during the procedure assessed by Visual Analog Pain Scale(VAS scale)(1 hour)
- Duration of the procedure in seconds(1 hour)
- Rate of sample suitable for next-generation sequencing(NGS) analysis based on percentage of neoplastic cell in samples(1 month)
研究者
Mario Tamburrini
Principal investigator
University Hospital of Ferrara
